on MEDINCELL (EPA:MEDCL)
MedinCell: Update of share capital and voting rights
On November 22, 2024, MedinCell communicated information regarding the number of shares comprising its share capital and total voting rights. Listed on Euronext Paris, Compartment B, the biopharmaceutical company specified that as of October 31, 29,103,380 shares were outstanding.
The total number of voting rights is 40,894,096 gross, including shares without voting rights, in accordance with AMF legislation. Net voting rights exercisable at the General Meeting amount to 40,881,596.
This data provides an overview of MedinCell's capital structure and helps investors monitor potential developments in corporate governance.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all MEDINCELL news